Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Mexiletine hydrochloride

EU orphan designation number: EU/3/13/1126   
Active ingredient: Mexiletine hydrochloride
Indication: Treatment of non-dystrophic myotonia
Sponsor: Prof Michael Hanna
MRC Centre for Neuromuscular Diseases, 8-11 Queen Square, London, WC1N 3BG, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/06/2013 Centralised Orphan - Designation EMA/OD/182/12 (2013)3662 of 07/06/2013